DNA methylation markers: a versatile diagnostic tool for routine clinical use

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Recent advancements in cancer treatment necessitate improved diagnostic and prognostic tools.
• Current diagnostic methods require enhancement for precise patient stratification.
• Biomarkers play a crucial role in personalized medicine and treatment selection.

Purpose of the Study:

• To review recent progress in the discovery of DNA methylation biomarkers for various neoplasias.
• To summarize the translation of these biomarkers into routine clinical practice.
• To highlight the potential of DNA methylation markers in improving cancer diagnosis and treatment selection.

Main Methods:

• Review of recent scientific literature on DNA methylation marker discovery.
• Analysis of studies focusing on the clinical application of DNA methylation biomarkers.
• Synthesis of information regarding the reliability and utility of these biomarkers in patient specimens.

Main Results:

• DNA methylation biomarkers are emerging as powerful tools in oncology.
• These biomarkers reflect critical aspects of tumor biology.
• Reliable measurement on routinely available patient samples is feasible.

Conclusions:

• DNA methylation biomarkers are highly promising for enhancing cancer diagnosis and treatment selection.
• Continued research and development are crucial for their widespread clinical adoption.
• These biomarkers represent a significant step forward in precision oncology.